Onesource Specialty Pharma Limited
ONESOURCE.NS- 1D
- +1.2%
Onesource Specialty Pharma Limited in brief
Onesource Specialty Pharma Limited is a listed company in the Healthcare sector, based in India. Its market value was $2.0 B on 19 November 2026, which makes it the 6,399th largest listed company in the world and the 395th largest in India on this site. Its shares trade under the symbol ONESOURCE.NS (NSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Onesource Specialty Pharma Limited timeline
- 2025
- 📈Listed on National Stock Exchange of India as ONESOURCEFirst day of listing in the exchange's official list.
Events of Onesource Specialty Pharma Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Onesource Specialty Pharma Limited share price · NSE (ONESOURCE.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | 1,587 | 1,617 | 1,570 | 1,603 | +1.1% | 126,006 |
| Nov 18, 2026 | 1,581 | 1,592 | 1,563 | 1,586 | +0.3% | 159,423 |
| Nov 17, 2026 | 1,612 | 1,614 | 1,578 | 1,581 | -2.0% | 210,366 |
| Nov 16, 2026 | 1,615 | 1,650 | 1,588 | 1,613 | +0.2% | 311,345 |
| Nov 13, 2026 | 1,620 | 1,688 | 1,601 | 1,610 | -0.6% | 599,203 |
| Nov 12, 2026 | 1,583 | 1,635 | 1,577 | 1,620 | +2.4% | 277,501 |
| Nov 11, 2026 | 1,621 | 1,644 | 1,577 | 1,582 | -2.2% | 221,763 |
| Nov 9, 2026 | 1,625 | 1,650 | 1,610 | 1,618 | +1.1% | 165,587 |
| Nov 6, 2026 | 1,582 | 1,619 | 1,566 | 1,600 | +1.1% | 276,774 |
| Nov 5, 2026 | 1,610 | 1,644 | 1,570 | 1,582 | -0.1% | 654,875 |
| Nov 4, 2026 | 1,585 | 1,600 | 1,566 | 1,584 | +0.9% | 481,453 |
| Nov 3, 2026 | 1,569 | 1,575 | 1,536 | 1,569 | +0.7% | 318,991 |
| Nov 2, 2026 | 1,563 | 1,602 | 1,542 | 1,558 | -0.3% | 329,034 |
| Oct 30, 2026 | 1,575 | 1,600 | 1,541 | 1,563 | -0.4% | 954,663 |
| Oct 29, 2026 | 1,585 | 1,598 | 1,564 | 1,570 | -0.5% | 736,956 |
| Oct 28, 2026 | 1,620 | 1,643 | 1,560 | 1,578 | -0.8% | 3.8 M |
| Oct 27, 2026 | 1,403 | 1,605 | 1,384 | 1,590 | +13.8% | 7.8 M |
| Oct 26, 2026 | 1,334 | 1,405 | 1,326 | 1,397 | +4.7% | 228,373 |
| Oct 23, 2026 | 1,378 | 1,378 | 1,321 | 1,334 | -3.2% | 206,529 |
| Oct 22, 2026 | 1,358 | 1,385 | 1,326 | 1,378 | +1.5% | 108,051 |
| Oct 21, 2026 | 1,366 | 1,385 | 1,331 | 1,357 | -0.7% | 216,713 |
| Oct 19, 2026 | 1,413 | 1,413 | 1,352 | 1,367 | -2.9% | 92,387 |
| Oct 16, 2026 | 1,448 | 1,448 | 1,402 | 1,408 | -1.8% | 103,563 |
| Oct 15, 2026 | 1,440 | 1,442 | 1,421 | 1,433 | -0.6% | 85,979 |
| Oct 14, 2026 | 1,459 | 1,460 | 1,424 | 1,442 | -1.1% | 303,380 |
| Oct 13, 2026 | 1,469 | 1,478 | 1,435 | 1,459 | -0.8% | 228,818 |
| Oct 12, 2026 | 1,461 | 1,504 | 1,443 | 1,471 | +0.7% | 167,234 |
| Oct 9, 2026 | 1,479 | 1,491 | 1,438 | 1,461 | -1.1% | 194,585 |
| Oct 8, 2026 | 1,528 | 1,535 | 1,463 | 1,478 | -3.3% | 232,650 |
| Oct 7, 2026 | 1,529 | 1,548 | 1,511 | 1,529 | — | 101,988 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Onesource Specialty Pharma Limited share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #390 (Nov 2026) · #395 (Nov 2026) · #392 (Nov 2026) · #397 (Nov 2026) · #394 (Nov 2026) · #395 (Nov 2026)
Mutual funds holding Onesource Specialty Pharma Limited#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇮🇳 Motilal Oswal Large and Midcap FundMotilal Oswal Asset Management | 3.84 M | $63 M | — | 3.0% | +3.1% | Oct 31, 2026 |
| 🇮🇳 Motilal Oswal Flexicap FundMotilal Oswal Asset Management | 2.47 M | $41 M | — | 2.9% | +3.4% | Oct 31, 2026 |
| 🇺🇸 Fidelity Blue Chip Growth FundFidelity Management & Research Company LLC | 2.02 M | $34 M | — | 0.03% | no change | Jul 31, 2026 |
| 🇮🇳 Motilal Oswal ELSS Tax Saver FundMotilal Oswal Asset Management | 1.09 M | $18 M | — | 3.6% | no change | Oct 31, 2026 |
| 🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc. | 732,216 | $12 M | — | <0.01% | −5.0% | Jul 31, 2026 |
| 🇺🇸 Vanguard Emerging Markets Stock Index FundThe Vanguard Group, Inc. | 689,229 | $12 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares Core MSCI Emerging Markets ETFBlackRock Fund Advisors | 551,156 | $11 M | — | <0.01% | +1.3% | May 31, 2026 |
| 🇮🇳 Aditya Birla Sun Life Flexi Cap FundAditya Birla Sun Life AMC | 485,952 | $8 M | — | 0.27% | no change | Oct 31, 2026 |
| 🇮🇳 Aditya Birla Sun Life Value FundAditya Birla Sun Life AMC | 440,404 | $7 M | — | 1.1% | no change | Oct 31, 2026 |
| 🇺🇸 Fidelity Blue Chip Growth K6 FundFidelity Management & Research Company LLC | 414,000 | $7 M | — | 0.03% | no change | Jul 31, 2026 |
| 🇺🇸 Fidelity Series Blue Chip Growth FundFidelity Management & Research Company LLC | 373,400 | $6 M | — | 0.04% | no change | Jul 31, 2026 |
| 🇮🇳 Motilal Oswal Active Momentum FundMotilal Oswal Asset Management | 244,150 | $4 M | — | 2.6% | no change | Oct 31, 2026 |
| 🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc. | 194,252 | $3 M | — | 0.02% | +8.7% | Jul 31, 2026 |
| 🇺🇸 State Street SPDR Portfolio Emerging Markets ETFSSGA Funds Management, Inc. | 156,983 | $3 M | — | 0.02% | no change | Jun 30, 2026 |
| 🇮🇳 Motilal Oswal Small Cap FundMotilal Oswal Asset Management | 152,251 | $3 M | — | 0.29% | −70% | Oct 31, 2026 |
| 🇮🇳 Nippon India Nifty Smallcap 250 Index FundNippon Life India Asset Management | 116,885 | $2 M | — | 0.58% | −4.0% | Oct 31, 2026 |
| 🇺🇸 iShares Core MSCI Total International Stock ETFBlackRock Fund Advisors | 110,204 | $2 M | — | <0.01% | +1.3% | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust | 96,404 | $2 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 iShares MSCI India Small-Cap ETFBlackRock Fund Advisors | 81,952 | $2 M | — | 0.25% | −6.2% | May 31, 2026 |
| 🇮🇳 Aditya Birla Sun Life Special Opportunities FundAditya Birla Sun Life AMC | 87,060 | $1 M | — | 1.0% | +53% | Oct 31, 2026 |
| 🇮🇳 SBI Nifty Smallcap 250 Index FundSBI Funds Management | 62,262 | $1 M | — | 0.58% | +0.7% | Oct 31, 2026 |
| 🇮🇳 Aditya Birla Sun Life Pharma & Healthcare FundAditya Birla Sun Life AMC | 60,000 | $1 M | — | 0.86% | new | Oct 31, 2026 |
| 🇮🇳 Aditya Birla Sun Life Manufacturing Equity FundAditya Birla Sun Life AMC | 59,397 | $1 M | — | 0.70% | no change | Oct 31, 2026 |
| 🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc. | 44,645 | $1 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇮🇳 Motilal Oswal Nifty Smallcap 250 Index FundMotilal Oswal Asset Management | 43,871 | $1 M | — | 0.58% | +0.0% | Oct 31, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 39,840 | $1 M | — | <0.01% | +22% | Jun 30, 2026 |
| 🇺🇸 Fidelity Total International Index FundFidelity Management & Research Company LLC | 35,543 | $1 M | — | <0.01% | +21% | Jul 31, 2026 |
| 🇮🇳 Nsmall50Aditya Birla Sun Life AMC | 30,867 | $1 M | — | 1.5% | −8.5% | Oct 31, 2026 |
| 🇮🇳 Tata Nifty Midsmall Healthcare Index FundTata Asset Management | 28,574 | $0 M | — | 1.9% | +7.2% | Oct 31, 2026 |
| 🇮🇳 Motilal Oswal Special Opportunities FundMotilal Oswal Asset Management | 23,327 | $0 M | — | 3.0% | no change | Oct 31, 2026 |
| 🇺🇸 iShares MSCI Emerging Markets Small-Cap ETFBlackRock Fund Advisors | 12,528 | $0 M | — | 0.06% | no change | May 31, 2026 |
| 🇺🇸 State Street Global All Cap Equity ex-U.S. Index PortfolioSSGA Funds Management, Inc. | 13,121 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇮🇳 Motilal Oswal Nifty 500 Index FundMotilal Oswal Asset Management | 12,913 | $0 M | — | 0.06% | +2.0% | Oct 31, 2026 |
| 🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc. | 10,833 | $0 M | — | <0.01% | −31% | May 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Value ETFAmerican Century ETF Trust | 7,814 | $0 M | — | 0.01% | no change | May 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Asia Pacific ETFSSGA Funds Management, Inc. | 8,307 | $0 M | — | 0.03% | +7.7% | Jun 30, 2026 |
| 🇮🇳 Motilal Oswal Nifty Smallcap 250 ETFMotilal Oswal Asset Management | 8,720 | $0 M | — | 0.58% | −1.4% | Oct 31, 2026 |
| 🇮🇳 Nippon India Nifty 500 Equal Weight Index FundNippon Life India Asset Management | 5,793 | $0 M | — | 0.21% | +0.7% | Oct 31, 2026 |
| 🇮🇳 Tata Nifty500 Multicap India Manufacturing 50-30-20 Index FundTata Asset Management | 4,290 | $0 M | — | 0.49% | +6.5% | Oct 31, 2026 |
| 🇺🇸 State Street SPDR Portfolio MSCI Global Stock Market ETFSSGA Funds Management, Inc. | 3,817 | $0 M | — | <0.01% | +13% | Jun 30, 2026 |
| 🇮🇳 SBI Nifty 500 Index FundSBI Funds Management | 3,056 | $0 M | — | 0.06% | +1.6% | Oct 31, 2026 |
| 🇺🇸 Avantis Responsible Emerging Markets Equity ETFAmerican Century ETF Trust | 1,868 | $0 M | — | 0.02% | −5.6% | May 31, 2026 |
| 🇮🇳 Motilal Oswal Nifty 500 ETFMotilal Oswal Asset Management | 1,225 | $0 M | — | 0.06% | no change | Oct 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust | 1,049 | $0 M | — | 0.02% | no change | May 31, 2026 |
| 🇺🇸 Avantis Emerging Markets ex-China Equity ETFAmerican Century ETF Trust | 938 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP | 3 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Oct 31, 2026. The 46 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Where Onesource Specialty Pharma Limited operates: 1 country#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Only the headquarters country is on file for Onesource Specialty Pharma Limited: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.
| Country | Presence | Revenue there |
|---|---|---|
| 🇮🇳 India | Headquarters | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
FDA drug approvals: Onesource Specialty Pharma Limited#
46 approved applications held; 1 approvals and 0 new uses in 2025.
| Approved | Drug | Kind |
|---|---|---|
| 2025-03-05 | Levothyroxine SodiumLevothyroxine Sodium · ANDA216729 | Generic drug (ANDA) |
| 2024-11-21 | Sumatriptan SuccinateSumatriptan Succinate · ANDA215651 | Generic drug (ANDA) |
| 2024-10-29 | Thiamine HydrochlorideThiamine Hydrochloride · ANDA217181 | Generic drug (ANDA) |
| 2024-10-03 | Methohexital SodiumMethohexital Sodium · ANDA215488 | Generic drug (ANDA) |
| 2023-09-22 | Icosapent EthylIcosapent Ethyl · ANDA217844 | Generic drug (ANDA) |
| 2023-07-25 | Carboprost TromethamineCarboprost Tromethamine · ANDA216897 | Generic drug (ANDA) |
| 2023-04-19 | AcetylcysteineAcetylcysteine · ANDA217182 | Generic drug (ANDA) |
| 2022-12-23 | Mycophenolate Mofetil HydrochlorideMycophenolate Mofetil Hydrochloride · ANDA216390 | Generic drug (ANDA) |
| 2022-08-17 | Naproxen SodiumNaproxen Sodium · ANDA215472 | Generic drug (ANDA) |
| 2022-08-02 | CyclosporineCyclosporine · ANDA216046 | Generic drug (ANDA) |
| 2022-02-18 | Amantadine HydrochlorideAmantadine Hydrochloride · ANDA211354 | Generic drug (ANDA) |
| 2021-08-11 | Loperamide HydrochlorideLoperamide Hydrochloride · ANDA213070 | Generic drug (ANDA) |
| 2020-01-15 | LoratadineLoratadine · ANDA211926 | Generic drug (ANDA) |
| 2019-12-03 | Diclofenac PotassiumDiclofenac Potassium · ANDA210078 | Generic drug (ANDA) |
| 2019-02-19 | EthosuximideEthosuximide · ANDA211928 | Generic drug (ANDA) |
| 2018-03-28 | IbuprofenIbuprofen · ANDA204469 | Generic drug (ANDA) |
| 2017-11-17 | Ganciclovir SodiumGanciclovir Sodium · ANDA204560 | Generic drug (ANDA) |
| 2017-09-19 | Omega-3-Acid Ethyl EstersOmega-3-Acid Ethyl Esters · ANDA203893 | Generic drug (ANDA) |
| 2017-07-21 | Cetirizine Hydrochloride AllergyCetirizine Hydrochloride · ANDA205291 | Generic drug (ANDA) |
| 2015-11-20 | DutasterideDutasteride · ANDA204262 | Generic drug (ANDA) |
| 2015-07-30 | BenzonatateBenzonatate · ANDA091133 | Generic drug (ANDA) |
| 2014-12-12 | CalcitriolCalcitriol · ANDA091356 | Generic drug (ANDA) |
| 2014-08-25 | Oxacillin SodiumOxacillin Sodium · ANDA091486 | Generic drug (ANDA) |
| 2014-08-15 | Piperacillin And TazobactamPiperacillin Sodium, Tazobactam Sodium · ANDA065458 | Generic drug (ANDA) |
| 2014-08-04 | Ketorolac TromethamineKetorolac Tromethamine · ANDA201155 | Generic drug (ANDA) |
Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (ONESOURCE SPECIALTY and ONESOURCE), so they follow acquisitions
Product recalls by Onesource Specialty Pharma Limited#
1 recalls since 2015, 4,284 units in the notices that give a number. Drugs (FDA): 1.
| Date | What and why | Units | Notice |
|---|---|---|---|
| Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31Failed Impurities/Degradation SpecificationsDrugsClass II | 4,284 | D-0662-2026 |
Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness
Discuss Onesource Specialty Pharma Limited#
1 automatic updates and 0 member comments. Sign in to comment and react.
- Mutual funds: 46 funds hold $249 millionautomatic update · Oct 31, 2026
46 mutual funds in 2 countries hold shares of Onesource Specialty Pharma Limited worth $249 million (funds' newest reports, up to 31 October 2026). Since their previous reports 18 funds added shares and 22 sold; on balance they sold $5 million. Share splits are not counted as trading.
How Onesource Specialty Pharma Limited compares in Healthcare
- Market cap$2.0 B · higher than 73% of 2,013
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Onesource Specialty Pharma Limited🇮🇳 | $2.0 B | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Nov 19, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, value.today research, GLEIF register.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Onesource Specialty Pharma Limited? Verify and update this profile — free
Show Onesource Specialty Pharma Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.